mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.05 |